NCT03822520View on ClinicalTrials.gov

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

May 25, 2018

Study Completion Date

May 25, 2018

Conditions
Qt Interval, Variation in
Interventions
DRUG

Celecoxib

Celecoxib 400mg capsule

DRUG

Moxifloxacin

Moxifloxacin 400mg tablet

OTHER

Water

Pure water 150ml

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03822520 - Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib | Biotech Hunter | Biotech Hunter